The PI3K/Akt/mTOR pathway in ovarian cancer:therapeutic opportunities and challenges |
| |
摘 要: | The phosphatidylinositol 3 kinase (PI3K) pathway is frequently altered in cancer, including ovarian cancer (OC). Unfortunately, despite a sound biological rationale and encouraging activity in preclini...
|
本文献已被 万方数据 等数据库收录! |
|